The independent source for health policy research, polling, and news.
21-40 of 238 results
KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
At a January event organized by allies of health secretary Robert F. Kennedy Jr., National Cancer Institute Director Anthony Letai said results may be released “in a few months.” Ivermectin, used to deworm horses and other animals, has become a symbol of resistance against the medical establishment among supporters of Kennedy’s “Make America Healthy Again” agenda and many conservatives.
The Trump administration has made the future of federal funding for cancer research uncertain. At one groundbreaking breast cancer research lab, work that could save lives has slowed significantly.
Many shots seem to have “off-target” benefits, such as lowering the risk of dementia, studies have found.
In 2026, U.S. cancer registries that receive federal funding will be required by the Trump administration to classify patients’ sex as only male, female, or not stated/unknown.
Under Trump policies, cancer registries in 2026 will have to classify sex data strictly as male, female, or unknown, a change scientists and advocates say will harm the health of one of the nation’s most marginalized populations.
Eric Tennant’s doctors recommended histotripsy, which would target, and potentially destroy, a cancerous tumor in his liver. But by the time his insurer approved the treatment, Tennant was no longer considered a good candidate. He died in September.
After a total glossectomy and laryngectomy to treat her cancer, Sonya Sotinsky can no longer speak. She searched for a way to sound like herself again and now pays out-of-pocket for an artificial intelligence app that can replicate her old voice — emotion, inflection, and all.
KFF Health News gives readers a chance to comment on a recent batch of stories.
KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
Although racial disparities in the diagnosis and treatment of multiple myeloma remain, Black survivors of multiple myeloma say the latest developments in treatment give them hope even as federal research cuts create a grim forecast for cancer research.
A standoff in Congress is keeping much of the government shut down as open enrollment begins in most states for Affordable Care Act plans. Democrats are demanding Republicans agree to extend ACA tax credits, but there has been little negotiating — even as customers are learning what they’ll pay for coverage next year. Meanwhile, the Trump administration is telling states they can’t pass their own laws to keep medical debt off consumers’ credit reports. Paige Winfield Cunningham of The Washington Post, Maya Goldman of Axios, and Alice Miranda Ollstein of Politico join KFF Health News’ Julie Rovner to discuss those stories and more.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
Despite a poisonous political climate, hundreds of volunteer advocates put partisan differences aside and pressed Congress to help people with cancer.
People who maintained the nation’s land-based nuclear missile arsenal are coming down with similar cancers. The Air Force is wrapping up a large study of the health risks they may have faced.
Fewer people are seeking care at the National Institutes of Health Clinical Center, a renowned research hospital, under the second Trump administration.
KFF Health News journalists made the rounds on national media recently to discuss topical stories. Here’s a collection of their appearances.
The Health and Human Services secretary is winding down nearly $500 million in mRNA research funding, citing false claims that the technology is ineffective against respiratory illnesses — and notching a victory for critics of the covid vaccines. And President Donald Trump is demanding drugmakers drop their prices, quickly, but it’s unclear how he could make them comply. Lauren Weber of The Washington Post, Sandhya Raman of CQ Roll Call, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News’ Emmarie Huetteman to discuss these stories and more.
The renowned research hospital that cares for people with rare or life-threatening diseases has been pummeled by an employee exodus and the gutting of research, both driven by the Trump administration.
© 2026 KFF